It is disappointing that despite the substantial advances in our understanding of the molecular basis of disease, there is a paucity of approved biomarkers. Protein biomarkers in biological fluids in particular, have the potential to inform regarding risk of disease or to allow early detection for more effective treatment.
No takes yet. Share an insight, caveat, or question.
Samir Hanash (2011) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: